Millions of people undergo ENT surgery every year. ArthroCare ENT is working to make ENT surgery a better experience by providing ENT specialists with advanced tools and alternative procedures based on Coblation® technology.
Since we received U.S. Food and Drug administration clearance in 2000 for our first ENT-based procedure, we have continued to advance the application of Coblation technology for tonsillectomies, adenoidectomies, and the treatment of snoring and chronic stuffy nose. The benefits of these procedures have led to their adoption by ENT physicians throughout the world.
Explore our website to learn how our products and procedures are helping to make ENT surgery a better experience for physicians and patients alike.
ArthroCare ENT Milestones:
2006 |
January |
Acquisition of ATI Inc, maker of Rapid Rhino epistaxis products |
2005 |
January |
Launch of EVac® 70 Xtra Wand |
2003 |
October |
FDA Clearance for Integrated Cable Wands (ICW) |
February |
FDA Clearance for Coblator® II Surgery System | |
2001 |
July |
FDA Clearance for Coblation-Assisted Tonsillectomy and Adenoidectomy |
2000 |
May |
FDA Clearance for Coblation-Assisted Nasal Turbinate Reduction |
February |
FDA Clearance for Coblation-Assisted Soft Palate Treatment for Snoring | |
1998 |
May |
ArthroCare Announces Formation of ENT Business Unit |
January |
First FDA General Clearance for ENT |